Idexx Laboratories 

$541.31
344
-$4.42-0.81% Tuesday 20:00
-$0.56-0.1%Tuesday 23:05After hours

Statistics

Day High
551.61
Day Low
538.44
52W High
769.98
52W Low
506.91
Volume
646,571
Avg. Volume
596,100
Mkt Cap
43.1B
P/E Ratio
41.33
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.4
2.92
3.44
3.96
Expected EPS
3.955202
Actual EPS
N/A

Financials

24.62%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
8.61BRevenue
2.12BNet Income

Analyst Ratings

719.17Average Price Target
The highest estimate is 800.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IDXX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Show more...
CEO
Mr. Jonathan J. Mazelsky
Employees
11000
Country
United States
ISIN
US45168D1046

Listings

0 Comments

Share your thoughts

FAQ

What is Idexx Laboratories stock price today?
The current price of IDXX is $541.31 USD — it has decreased by -0.81% in the past 24 hours. Watch Idexx Laboratories stock price performance more closely on the chart.
What is Idexx Laboratories stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Idexx Laboratories stocks are traded under the ticker IDXX.
Is Idexx Laboratories stock price growing?
IDXX stock has fallen by -0.88% compared to the previous week, the month change is a -3.23% fall, over the last year Idexx Laboratories has showed a +2.04% increase.
What is Idexx Laboratories market cap?
Today Idexx Laboratories has the market capitalization of 43.1B
When is the next Idexx Laboratories earnings date?
Idexx Laboratories is going to release the next earnings report on August 04, 2026.
What were Idexx Laboratories earnings last quarter?
IDXX earnings for the last quarter are 3.47 USD per share, whereas the estimation was 3.41 USD resulting in a +1.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Idexx Laboratories revenue for the last year?
Idexx Laboratories revenue for the last year amounts to 8.61B USD.
What is Idexx Laboratories net income for the last year?
IDXX net income for the last year is 2.12B USD.
How many employees does Idexx Laboratories have?
As of June 24, 2026, the company has 11,000 employees.
In which sector is Idexx Laboratories located?
Idexx Laboratories operates in the Health & Wellness sector.
When did Idexx Laboratories complete a stock split?
The last stock split for Idexx Laboratories was on June 16, 2015 with a ratio of 2:1.
Where is Idexx Laboratories headquartered?
Idexx Laboratories is headquartered in Westbrook, United States.